Literature DB >> 23609064

Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.

Adil Jaulim1, Badia Ahmed, Tina Khanam, Irini P Chatziralli.   

Abstract

BACKGROUND/
PURPOSE: Retinal vein occlusion is the second most common retinal vascular disorder after diabetic retinopathy and is considered to be an important cause of visual loss. In this review, the purpose is to make an update of the literature about the classification, epidemiology, pathogenesis, risk factors, clinical features, and complications of branch retinal vein occlusion (BRVO).
METHODS: Eligible articles were identified using a comprehensive literature search of MEDLINE, using the terms "branch retinal vein occlusion," "pathogenesis," "epidemiology," "risk factors," "clinical features," "diagnosis," and "complications." Additional articles were also selected from reference lists of articles identified by the electronic database search.
RESULTS: Classification, epidemiology, pathogenesis, risk factors, clinical features, and complications are analyzed.
CONCLUSIONS: Branch retinal vein occlusion has an incidence of 0.5% to 1.2%. Several risk factors, such as hypertension, hyperlipidemia, diabetes mellitus, thrombophilia and hypercoagulation, systemic and inflammatory diseases, medications, and ocular conditions, have found to be associated with BRVO. The symptoms depended on the site and severity of the occlusion. The average reduction in visual acuity for ischemic BRVO is 20/50 and for nonischemic BRVO is 20/60. Acute BRVO can be detected by fundoscopy, where flame hemorrhages, dot and blot hemorrhages, cotton wool spots, hard exudates, retinal edema, and dilated tortuous veins can be observed. Chronic BRVO would be more subtle and characterized by the appearance of venous collateral formation and vascular sheathing, in addition to complications previously mentioned. Areas of ischemia can be evaluated using fluorescein angiography. The extent of macular edema and the presence of retinal detachment can be detected by fundoscopic examination or fluorescein angiography, although optical coherence tomography is considered to be the best method. As far as complications, the most common is macular edema, followed by retinal neovascularization, vitreous hemorrhage, or retinal detachment.

Entities:  

Mesh:

Year:  2013        PMID: 23609064     DOI: 10.1097/IAE.0b013e3182870c15

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  99 in total

1.  Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels.

Authors:  Jong Chan Im; Jae Pil Shin; In Taek Kim; Dong Ho Park
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-18       Impact factor: 3.117

2.  Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.

Authors:  Rika Yamada; Akihiro Nishida; Masataka Shimozono; Takanori Kameda; Noriko Miyamoto; Michiko Mandai; Yasuo Kurimoto
Journal:  Jpn J Ophthalmol       Date:  2015-09-03       Impact factor: 2.447

3.  Branch retinal vein occlusion: the importance of the topographical distribution of retinal vessels among risk factors.

Authors:  Z Oztas; C Akkin; S Nalcaci; O Ilim; F Afrashi
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

4.  Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience.

Authors:  Julie Blanc; Clémence Deschasse; Laurent Kodjikian; Corinne Dot; Alain-Marie Bron; Catherine Creuzot-Garcher
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-05-31       Impact factor: 3.117

5.  Occluded twice over but lucky: report of concealed macular branch retinal vein occlusion.

Authors:  Srikanta Kumar Padhy; Umesh Chandra Behera
Journal:  BMJ Case Rep       Date:  2019-05-16

6.  Poor outcomes despite aspirin or statin use in high-risk patients with retinal vein occlusion.

Authors:  Vlad M Matei; Jonathan Y Xia; Chan Nguyen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-12-21       Impact factor: 3.117

7.  Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion.

Authors:  Alper Halil Bayat; Akın Çakır; Şeyma Gülcenur Özturan; Selim Bölükbaşı; Burak Erden; Mustafa Nuri Elçioğlu
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

8.  Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria.

Authors:  Marc Sorigue; Jordi Juncà; Elisa Orna; Nevena Romanic; Edurne Sarrate; Jordi Castellvi; Montse Soler; Ines Rodríguez-Hernandez; Evarist Feliu; Susana Ruiz
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

9.  Comparison of immediate versus deferred intravitreal Bevacizumab in macular oedema due to branch retinal vein occlusion: a pilot study.

Authors:  M A Khan; Varakutti Mallika; Dattakiran Joshi
Journal:  Int Ophthalmol       Date:  2017-04-21       Impact factor: 2.031

10.  Developments in Ocular Genetics: 2013 Annual Review.

Authors:  Inas F Aboobakar; R Rand Allingham
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2014 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.